Study on the Impact of Coordinated Immunizations Against RSV and Influenza on the Prognosis in Patients With Chronic Heart Failure.
Status: Recruiting
Location: See location...
Intervention Type: Behavioral, Biological
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This prospective, single-centre, open-label, randomized study aims to determine whether coordinated care in administering protective vaccinations (against Respiratory Syncytial Virus (RSV) and influenza) impacts the prognosis of patients with chronic heart failure. The main question it aims to answer is: • Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age above 18 years
• Willingness to provide informed consent for participation in the study
• Diagnosis of heart failure
• No previous vaccination against RSV or influenza
Locations
Other Locations
Poland
Wroclaw Medical University
RECRUITING
Wroclaw
Contact Information
Primary
Jan Biegus, MD, PhD,
jan.biegus@uwm.edu.pl
71 736 42 05
Backup
Gracjan Iwanek, MD
gracjan.iwanek@student.umw.edu.pl
71 736 42 92
Time Frame
Start Date: 2023-09-15
Estimated Completion Date: 2024-07-30
Participants
Target number of participants: 250
Treatments
Experimental: Coordinated Vaccination against RSV and Influenza
Patients receiving vaccinations against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e. during cardiology visits).
Active_comparator: Standard of care
Patients following standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points).
Related Therapeutic Areas
Sponsors
Leads: Wroclaw Medical University